Despite a strong performance from the Nifty IT Index last year, recent uncertainties regarding Fed rate cuts and tariff wars ...
Following the most recent tariff warnings, the Nifty pharma index dropped by 0.9%, with 15 out of 20 companies experiencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results